Zobrazeno 1 - 5
of 5
pro vyhledávání: '"Axel Fogaça Rosado"'
Autor:
Axel Fogaça Rosado, Laura Menegatti Bevilacqua, Eduardo Luiz Gasnhar Moreira, Manuella Pinto Kaster
Publikováno v:
Progress in neuro-psychopharmacologybiological psychiatry. 123
Behavioral flexibility permits the appropriate behavioral adjustments in response to changing environmental demands. The present study aimed to evaluate if variability in baseline flexibility can enable differences in coping strategies, changes in ne
Antidepressant-like effect of guanosine involves activation of AMPA receptor and BDNF/TrkB signaling
Autor:
Yasmim de Oliveira Dalsenter, Morgana Moretti, Mauren K. Tavares, Priscila B. Rosa, Ana Lúcia S. Rodrigues, Daiane B. Fraga, Isabella A. Heinrich, Fernanda Neutzling Kaufmann, Luis E.B. Bettio, Vivian B. Neis, Andiara E. Freitas, Rodrigo B. Leal, Nicolle Platt, Isabel Werle, Axel Fogaça Rosado
Publikováno v:
Purinergic Signal
Guanosine is a purine nucleoside that has been shown to exhibit antidepressant effects, but the mechanisms underlying its effect are not well established. We investigated if the antidepressant-like effect induced by guanosine in the tail suspension t
Autor:
Vivian B. Neis, Nicole Platt, Priscila B. Rosa, Gislaine Olescowicz, Axel Fogaça Rosado, Morgana Moretti, Ana Lúcia S. Rodrigues
Publikováno v:
Naunyn-Schmiedeberg's Archives of Pharmacology. 393:1931-1939
Considering the involvement of GABAergic system in the action of the fast-acting antidepressant ketamine, and that agmatine may exert an antidepressant-like effect through mechanisms similar to ketamine, the purpose of the present study was to evalua
Autor:
Ana Lúcia Bertarello Zeni, Ana Lúcia S. Rodrigues, Ana Paula Dalmagro, Nicolle Platt, Vivian B. Neis, Anderson Camargo, Manuella P. Kaster, Axel Fogaça Rosado
Publikováno v:
Pharmacology, biochemistry, and behavior. 196
Several attempts have been made to understand the role of cholecalciferol (vitamin D3) in the modulation of neuropsychiatric disorders. Notably, the deficiency of vitamin D3 is considered a pandemic and has been postulated to enhance the risk of majo
Autor:
Priscila B. Rosa, Axel Fogaça Rosado, Isabel Werle, Morgana Moretti, Ana Lúcia S. Rodrigues, Vivian B. Neis, Fernanda Neutzling Kaufmann, Yasmim de Oliveira Dalsenter, Matheus Henrique Besen, Nicolle Platt
Publikováno v:
Pharmacology Biochemistry and Behavior. 198:173020
AZD6765 (lanicemine) is a non-competitive NMDA receptor antagonist that induces a fast-acting antidepressant effect without presenting psychotomimetic effects. However, the mechanisms underlying its effects remain to be established. In this context,